BA
GILD icon

Bridgewater Advisors’s Gilead Sciences GILD Stock Holding History

Bridgewater Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$781K Sell
5,957
-42
-0.7% -$5.53K 0.04% 198
2026
Q1 		$798K Sell
5,999
-159
-3% -$22.3K 0.05% 171
2025
Q4 		$795K Buy
6,158
+64
+1% +$7.78K 0.05% 176
2025
Q3 		$752K Sell
6,094
-54
-0.9% -$6.14K 0.05% 176
2025
Q2 		$702K Buy
6,148
+510
+9% +$54.3K 0.05% 180
2025
Q1 		$588K Buy
+5,638
New +$582K 0.05% 197

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bridgewater Advisors's GILD Position: Q2 2026 in Review

Bridgewater Advisors reduced its Gilead Sciences (GILD) stake by 0.7% in Q2 2026, selling an estimated $5.53K and leaving 5,957 shares worth $781K. The position accounts for 0.04% of the portfolio, ranked #198.

Bridgewater Advisors first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $798K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bridgewater Advisors held 5,957 shares of Gilead Sciences worth $781K as of Q2 2026.
  • Bridgewater Advisors sold 42 Gilead Sciences shares in Q2 2026, an estimated $5.53K.
  • Gilead Sciences made up 0.04% of Bridgewater Advisors's portfolio in Q2 2026, its #198 holding.
  • Bridgewater Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Bridgewater Advisors's Gilead Sciences position peaked at $798K in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.